Valuation: Novartis AG

Market Cap 279B 244B 226B 207B 392B 26,889B 399B 2,690B 1,055B 13,115B 1,048B 1,025B 45,319B P/E 2026 *
21.3x
P/E 2027 * 18x
Enterprise Value 311B 272B 252B 231B 437B 29,972B 445B 2,998B 1,176B 14,618B 1,168B 1,143B 50,515B EV / Sales 2026 *
5.47x
EV / Sales 2027 * 5.1x
Free-Float
91.66%
Yield 2026 *
2.89%
Yield 2027 * 2.98%
1 day+1.03%
1 week-2.10%
Current month-2.62%
1 month+2.53%
3 months+4.16%
6 months+7.67%
Current year+12.46%
1 week 121.06
Extreme 121.06
125.8
1 month 117.96
Extreme 117.96
128.92
Current year 107.68
Extreme 107.68
131
1 year 91.2
Extreme 91.2
131
3 years 81.1
Extreme 81.1
131
5 years 72.84
Extreme 72.84
131
10 years 65.09
Extreme 65.09
131
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Chief Tech/Sci/R&D Officer 64 16/05/2022
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Date Insider Type Main position Quantity % Market Cap.
5/18/26 A Sell -5,200 0.0003%
5/4/26 A Sell 6,800 0.0003%
2/17/26 A Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+1.03%-2.10%+28.32%+45.08% 277B
+1.08%-3.84%+51.50%+160.13% 1,031B
+1.19%-5.10%+61.09%+56.36% 595B
+4.21%+0.65%+36.48%+87.04% 431B
+0.42%-0.99%+30.04%+22.27% 326B
+0.49%-11.32%+20.31%+22.32% 263B
+1.59%+3.91%-22.47%-36.84% 224B
+3.70%+0.98%+27.03%+63.38% 193B
+3.49%+0.35%+24.98%+76.58% 164B
+1.29%+4.53%+2.15%-30.78% 141B
Average +0.42%-3.09%+25.94%+46.55% 364.58B
Weighted average by Cap. +0.15%-4.02%+36.41%+75.16%

Financials

2026 *2027 *
Net sales 56.91B 49.73B 46.02B 42.24B 79.9B 5,482B 81.35B 548B 215B 2,674B 214B 209B 9,239B 60.31B 52.71B 48.77B 44.77B 84.68B 5,810B 86.22B 581B 228B 2,834B 226B 222B 9,792B
Net income 14.08B 12.3B 11.39B 10.45B 19.77B 1,356B 20.13B 136B 53.22B 662B 52.86B 51.71B 2,286B 15.64B 13.67B 12.65B 11.61B 21.96B 1,507B 22.36B 151B 59.13B 735B 58.73B 57.45B 2,540B
Net Debt 32B 27.96B 25.88B 23.75B 44.93B 3,083B 45.74B 308B 121B 1,503B 120B 118B 5,195B 28.48B 24.89B 23.03B 21.14B 39.99B 2,744B 40.71B 274B 108B 1,338B 107B 105B 4,624B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
16/07/26 CHF 123.26 +1.03% 2,306,603
15/07/26 CHF 122.00 -0.34% 1,730,393
14/07/26 CHF 122.42 -1.73% 2,431,098
13/07/26 CHF 124.58 +0.24% 2,143,959
10/07/26 CHF 124.28 -0.02% 2,334,841
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
152.48USD
Average target price
152.96USD
Spread / Average Target
+0.32%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock